News & Updates

Show Multimedia Only

Should parenteral nutrition start at a lower birth weight threshold?

11 May 2023

A recent single-centre study, which reduced the birth weight (BW) threshold for bridging parenteral nutrition (PN) from 1,500 to 1,250 g, has found that PN was initiated in about one in four infants with a BW between 1,250 and 1,500 g.

11 May 2023

Over-the-scope clips outdoes standard treatment in preventing GI bleeding

11 May 2023 by

Initial treatment with over-the-scope clips (OTSCs) appears superior to standard endoscopic treatment in reducing the risk for further bleeding from nonvariceal upper gastrointestinal causes that are responsive to OTSC placement, results of a study have shown.

11 May 2023

Motivational interviewing plus CBT eases negative symptoms in schizophrenia

11 May 2023

Motivational interviewing (MI) in combination with cognitive behavioural therapy (CBT) improves negative symptoms in patients with schizophrenia, reports a study. These symptoms are initially thought of as resistant to any intervention.

11 May 2023

Switching to brolucizumab improves visual acuity in nAMD

11 May 2023 by

Switching from other anti-VEGF* agents to brolucizumab only helps improve visual acuity and reduces disease activity in patients with neovascular (wet) age-related macular degeneration (nAMD)

11 May 2023

Can antipsychotic monotherapy prevent hospitalizations in schizophrenia?

10 May 2023

A recent study has shown that antipsychotic monotherapy does not reduce the risk of hospitalization for severe physical health problems when compared with polypharmacy in patients with schizophrenia.

10 May 2023

Influenza vaccine wards off cardiovascular events, death in CAD patients

10 May 2023 by

A meta-analysis of randomized trials has revealed that influenza vaccination is effective at preventing all-cause mortality, cardiovascular mortality, major acute cardiovascular events, and acute coronary syndrome (ACS) among patients with coronary artery disease (CAD), particularly in those with ACS.

10 May 2023

Memantine therapy lessens hair pulling, skin picking in adults

10 May 2023

Treatment with memantine significantly reduces hair pulling and skin-picking symptoms when compared with placebo, demonstrating relatively high efficacy and tolerability, reports a study.

10 May 2023

Donanemab BLAZEs through Alzheimer’s treatment TRAIL in first active comparator trial

10 May 2023 by

The first study to directly compare two disease-modifying agents for Alzheimer’s disease (AD), the phase III TRAILBLAZER-ALZ 4 study shows promising efficacy and safety data on donanemab vs aducanumab for the treatment of early symptomatic AD.